EXPO — Exponent, Inc.
NASDAQ
Q4 2025 Earnings Call Summary
February 5, 2026
Summary of Exponent, Inc. (EXPO) Q4 2025 Earnings Call
1. Key Financial Results and Metrics
Q4 2025 Performance:
- Total revenues increased by 8% to $147.4 million; net revenues rose 5% to $129.4 million.
- Adjusted for one less week in the quarter, net revenues would have grown in the low double digits.
- Net income was $24.8 million ($0.49 per diluted share), up from $23.6 million ($0.46 per diluted share) in Q4 2024.
- EBITDA for the quarter was $34.7 million, with a margin of 26.8% of net revenues, compared to 25.2% in Q4 2024.
- Billable hours decreased by 1% year-over-year, but would have increased by 6% when adjusted for the extra week.
- Average technical full-time equivalent employees increased by 5% to 992.
Full Year 2025 Performance:
- Total revenues grew 4% to $582 million; net revenues also increased by 4% to $536.8 million.
- Net income decreased by 3% to $106 million ($2.07 per diluted share).
- EBITDA was $148.1 million, with a margin of 27.6%, down from 28.4% in 2024.
- Capital expenditures totaled $9.4 million.
- Cash and cash equivalents at year-end were $221.9 million.
2. Strategic Updates and Business Highlights
- Growth in proactive engagements was driven by increased demand for user research in consumer electronics and risk management services in the utility sector.
- Reactive services saw growth from failure analysis and dispute-related engagements across various industries, including energy and transportation.
- Exponent is leveraging AI within its operations to enhance efficiency and support complex investigations, particularly in safety-critical applications.
- The company highlighted its multidisciplinary expertise as a key differentiator in addressing complex challenges arising from AI and other advanced technologies.
3. Forward Guidance and Outlook
- For Q1 and full year 2026, Exponent expects net revenues to grow in the high single digits.
- EBITDA margins for Q1 2026 are projected to be between 27.5% and 28.5%; for the full year, between 27.6% and 28.1%.
- Anticipated headcount growth of approximately 4% year-over-year, with utilization expected to improve slightly.
- Realized rate increases are expected to be 3.5% to 4% for Q1 and 3% to 3.5% for the full year.
4. Bad News, Challenges, or Points of Concern
- Net income for the full year decreased by 3%, attributed to a negative tax impact from share-based awards.
- Utilization for the full year 2025 was slightly down at 72.5%, compared to 72.9% in 2024.
- The environmental & health segment saw a revenue decline of 5% in Q4, primarily due to the shorter quarter.
- Interest income decreased due to lower cash levels and interest rates, impacting overall financial performance.
5. Notable Q&A Insights
- Management expressed optimism about the consumer electronics segment, noting a resurgence in user research engagements, particularly for health-related products and AI-integrated devices.
- There was a focus on the energy sector as a significant growth driver for 2026, with ongoing demand for risk management and regulatory support.
- Concerns were raised about clients attempting to use AI independently, which sometimes leads to suboptimal outcomes, highlighting the need for Exponent's expertise.
- Management indicated that AI is seen as a net benefit to growth, enhancing capabilities in failure analysis and user research.
- Expectations for free cash flow in 2026 are positive, with efforts to improve Days Sales Outstanding (DSOs) to enhance cash conversion.
Overall, Exponent demonstrated resilience and growth potential, particularly in sectors driven by technological advancements, while also facing challenges in profitability and certain revenue segments.
